Previous studies showed that low serum bilirubin concentrations are associated with increased risk of cardiovascular disease. To explore this further, we evaluated the relationships between serum bilirubin concentrations and the degree of urinary albumin excretion and other markers of subclinical atherosclerosis in 633 consecutive patients with type 2 diabetes. Multiple regression analysis showed that the serum bilirubin concentration was an independent determinant of and had a significant inverse correlation to the log urinary albumin excretion. Serum bilirubin concentrations were significantly lower in patients with than in those without cardiovascular disease. A significant inverse correlation was found between the serum bilirubin concentration and pulse wave velocity, while a significant positive correlation was found to the anklebrachial index in a subgroup of 386 patients. Our study shows that the serum bilirubin level is associated with microalbuminuria and subclinical atherosclerosis in patients with type 2 diabetes.
Previous studies showed that low serum bilirubin concentrations are associated with increased risk of cardiovascular disease. To explore this further, we evaluated the relationships between serum bilirubin concentrations and the degree of urinary albumin excretion and other markers of subclinical atherosclerosis in 633 consecutive patients with type 2 diabetes. Multiple regression analysis showed that the serum bilirubin concentration was an independent determinant of and had a significant inverse correlation to the log urinary albumin excretion. Serum bilirubin concentrations were significantly lower in patients with than in those without cardiovascular disease. A significant inverse correlation was found between the serum bilirubin concentration and pulse wave velocity, while a significant positive correlation was found to the anklebrachial index in a subgroup of 386 patients. Our study shows that the serum bilirubin level is associated with microalbuminuria and subclinical atherosclerosis in patients with type 2 diabetes. Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in patients with type 2 diabetes. 1, 2 Previous studies have reported that low serum bilirubin concentrations are associated with an increased risk of CVD. 3, 4 Conversely, higher serum bilirubin concentrations were associated with decreased risk of CVD in a prospective study of serum bilirubin and CVD in the Framingham Offspring Study. 5 Furthermore, individuals with Gilbert syndrome, who have mildly elevated serum bilirubin concentration, were found to have a low rate of CVD. 6 Recently Inoguchi et al. 7 reported lower prevalence of vascular complications (for example coronary artery disease, cerebrovascular disease, retinopathy, or macroalbuminuria) in patients with diabetes and Gilbert syndrome.
Oxidized low-density lipoprotein may be important in the atherosclerotic process. Studies indicate that bilirubin, a major intravascular product of heme catabolism, is an effective antioxidant that effectively scavenges peroxyl radicals and suppress the oxidation of lipids and lipoproteins and thus acts against plaque formation and subsequent atherosclerosis. 8 Although previous studies have shown that elevated serum bilirubin concentrations provide protection against atherosclerotic disease, it is not clear whether higher serum bilirubin concentrations work in favor of the cardiovascular system in patients with type 2 diabetes. Moreover, there has been no study investigating the effects of serum bilirubin concentrations on diabetic nephropathy. Elevated urinary albumin excretion has been reported to be a marker of CVD as well as degree of diabetic nephropathy. 9 In this study, we evaluated the relationships between serum bilirubin concentrations and degree of urinary albumin excretion as well as markers of subclinical atherosclerosis such as pulse wave velocity (PWV) or ankle-brachial index (ABI) in patients with type 2 diabetes.
RESULTS
Characteristics of the 633 patients with type 2 diabetes enrolled in this study are shown in Table 1 . Relationships between serum bilirubin concentration and other variables are shown in Table 2 . Duration of diabetes and serum triglyceride concentration were inversely associated with serum bilirubin concentration. Age at onset and diastolic blood pressure were positively associated with serum bilirubin concentration. An inverse correlation was found between serum bilirubin concentration and PWV (r ¼ À0.114, P ¼ 0.0288), whereas a positive correlation was found between serum bilirubin concentration and ABI (r ¼ 0.118, P ¼ 0.0201). A positive correlation was found between serum bilirubin concentration and estimated glomerular filtration rate (r ¼ 0.106, P ¼ 0.0265). An inverse correlation was found between serum bilirubin concentration and logarithmic (log) (urinary albumin excretion) (r ¼ À0.202, Po0.0001; Figure 1 ). Multiple regression analysis demonstrated that age, duration of diabetes, hemoglobin A1C (HbA1c), systolic blood pressure, serum triglyceride concentration, and serum bilirubin concentration were independent determinants of log (urinary albumin excretion) ( Table 3 ). Comparisons of serum bilirubin concentration in various groups are shown in Table 4 . Serum bilirubin concentrations were lower in female patients than in male patients (P ¼ 0.0032). Serum bilirubin concentrations were lower in patients with proliferative diabetic retinopathy than in patients with no diabetic retinopathy (P ¼ 0.0017). Serum bilirubin concentrations were lower in patients with macroalbuminuria than in patients with normoalbuminuria (Po0.0001) or microalbuminuria (P ¼ 0.0012), and serum bilirubin concentrations were lower in patients with microalbuminuria than in patients with normoalbuminuria (P ¼ 0.0418). Serum bilirubin concentrations were lower in patients with CVD than without (P ¼ 0.0053). Serum bilirubin concentrations did not differ between patients treated with and without insulin (P ¼ 0.3863). Serum bilirubin concentrations were lower in patients with current smokers than in patients with past smokers (P ¼ 0.0294).
DISCUSSION
Serum bilirubin concentration correlated negatively with degree of urinary albumin excretion and correlated positively with estimated glomerular filtration rate, which suggests that bilirubin has a potential role for protection of diabetic nephropathy. Multiple regression analysis also identified serum bilirubin concentration as an independent determinant of log (urinary albumin excretion).
Ollinger et al. 10 found less balloon injury-induced neointima formation in hyperbilirubinemic rats treated with biliverdin, the precursor of bilirubin, than in controls, and demonstrated that bilirubin inhibited serum-driven smooth muscle cell-cycle progression at the G 1 phase in vitro. Bilirubin serves as a physiological antioxidant in ischemiareperfusion, 11 and serves a protective function against injurymediated proliferation of intimal cells in animal models. 12 On the basis of in vitro as well as animal studies, bilirubin is generally recognized as an important antioxidant substance. Kumar et al. 13 demonstrated that serum bilirubin concentration correlated inversely with a marker of oxidative stress and correlated positively with antioxidative enzyme activities such as superoxide dismutase, catalase, and glutathione peroxidase in jaundiced newborns. This is also supported by clinical studies focused on the protective effect of serum bilirubin concentrations on atherosclerosis. [3] [4] [5] Our study demonstrated that serum bilirubin concentrations were lower in patients with CVD than without. Furthermore, serum bilirubin concentrations correlated negatively with PWV and correlated positively with ABI, which are early preclinical markers of atherosclerosis, in patients with type 2 diabetes.
To explain plausible mechanisms of bilirubin action in preventing atherosclerosis, several mechanisms have been suggested. The most popular one is bilirubin-mediated inhibition of lipid oxidation. 8 Lipoproteins, particularly low-density lipoprotein cholesterol, are highly susceptible to oxidation, and it is known that the atherogenic process involves uptake of oxidized low-density lipoprotein by intimal macrophages leading to the accumulation of lipidrich foam cells. Given the antioxidant capacity of bilirubin, it is plausible that bilirubin protects lipids and lipoproteins against oxidation and thereby offers protection against atherosclerosis. Bilirubin is a more effective protector of human ventricular myocytes than several known antioxidants, such as vitamin C and vitamin E analogues. 14 Free bilirubin, albumin-bound bilirubin, conjugated bilirubin, and unconjugated bilirubin were all noted to be effective scavengers of peroxyl radicals and to be able to protect human low-density lipoprotein against peroxidation. 14, 15 Besides being an antioxidant, bilirubin also has anticomplement properties that protect against inflammation. 16 Furthermore, bilirubin has been suggested to have cytoprotective properties through its influence on protein kinase C. In vitro, protein kinase C increases the scavenger receptor expression in smooth muscle cells and therefore contributes to the formation of smooth muscle foam cells. 17 Mietus-Synder et al. 17 demonstrated that hyperbilirubinemia can improve endothelium-independent vasodilator functions of the coronary vasculature. The mechanisms described above are some of the important mechanisms of the development and progression of diabetic nephropathy [18] [19] [20] [21] or retinopathy, 21, 22 which may partially explain the association between serum bilirubin concentration and degree of diabetic nephropathy or retinopathy.
Surprisingly, the strength of serum bilirubin concentration as an independent determinant of log (urinary albumin excretion) was similar to those of known factors such as systolic blood pressure, HbA1c, and duration of diabetes in multiple regression analysis. Serum bilirubin concentration was an independent determinant of log (urinary albumin excretion) even after adjustment for treatment of hypertension and hyperlipidemia (Po0.0001). The clinical relevance relates to potential preventive and therapeutic approaches.
Smoking was reported to be highly correlated with low serum bilirubin concentration, 4 which was also found in the present study. Feasible strategies for boosting serum bilirubin concentration may include administration of drugs which decrease the efficacy of hepatic bilirubin conjugation such as uricosuric drug probenecid, 23 and administration of heme oxygenase-1 inducers such as lipoic acid and various bioavailable flavonoids. 23 The diagnostic relevance concerns the diagnostic utility of serum bilirubin concentrations, as a provisional new risk factor of diabetic nephropathy as well as atherosclerosis, which can be measured easily in the clinical laboratory and applied in medical practice.
Limitations of our study include a cross-sectional design. In addition, results in this study may not be applicable to general population or to patients with type 2 diabetes in a primary care clinic because patients in an outpatient clinic in a university hospital are selected patients. Furthermore, we have measured ABI oscillometrically, although Beckman et al. 24 demonstrated that oscillometric determination of the ABI was a reliable and easier method, which correlated well with Doppler ultrasound measurement of ABI. However, to our knowledge, this is the first study to investigate the relationship between serum bilirubin concentration and urinary albumin excretion as well as subclinical atherosclerosis in patients with type 2 diabetes. Although we are unable to determine whether hypobilirubinemia has a causative effect, these findings suggest that hypobilirubinemia combined with diabetes might be associated with advanced diabetic nephropathy and atherosclerosis. Large prospective trials are needed to better assess the effects of bilirubin on diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
MATERIALS AND METHODS Patients
Serum bilirubin concentrations were measured in 633 consecutive patients with type 2 diabetes recruited from the outpatient clinic at the Kyoto Prefectural University of Medicine. We then evaluated relationships of serum bilirubin concentrations to degree of urinary albumin excretion as well as to major cardiovascular risk factors, including age, blood pressure, serum lipid concentration, and glycemic control (HbA1c), body mass index (BMI), current treatment for diabetes, smoking status, and presence of CVD. The relationships between serum bilirubin concentrations and PWV or ABI (n ¼ 386) were investigated additionally in a subgroup of patients.
Clinical and biochemical assessment Type 2 diabetes was diagnosed according to the Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 25 Retinopathy was assessed by ophthalmoscope, and was graded as no diabetic retinopathy; simple diabetic retinopathy; or proliferative diabetic retinopathy. Nephropathy was graded as follows: normoalbuminuria, urinary albumin excretion less than 30 mg per gram of creatinine (mg/g Cr); microalbuminuria, 30-300 mg/g Cr; or macroalbuminuria, more than 300 mg/g Cr. GFR was estimated from the Modification of Diet in Renal Disease equation for Japanese patients. 26 Sitting blood pressure was measured after a 5-min rest. CVD was defined as a previous myocardial or cerebral infarction based on the clinical history or physical examination. Subjects were classified as nonsmokers, past smokers, or current smokers according to a self-administered questionnaire.
Patients with malignant disease, liver cirrhosis, or hematologic disease were excluded from this study. Patients with advanced renal dysfunction (serum creatinine more than 2.0 mg/100 ml) were also excluded. Furthermore, patients, whose serum bilirubin concentrations 41.2 mg/100 ml, were excluded because of the high possibility of Gilbert syndrome. Approval for the study was obtained from the local Research Ethics Committee, and informed consent was obtained from all participants.
Blood samples were taken in the morning. Total serum bilirubin concentrations (normal ranges: 0.2-1.0 mg/100 ml) were measured by an enzymatic method with bilirubin oxidase on an automatic analyzer (Hitachi 7600). Serum total cholesterol, high-density lipoprotein cholesterol, and triglyceride concentrations were assessed using standard enzymatic methods. HbA1c was assayed using high-performance liquid chromatography. Urinary albumin and creatinine concentration were determined in an early morning spot urine. Urinary albumin excretion was measured with an immunoturbidimetric assay. A mean value for urinary albumin excretion was determined from three urine collections.
Measurement of pulse wave velocity and ankle-brachial index
Brachial-ankle PWV and ABI were measured using a Colin Waveform Analyzer (form PWV/ABI; Colin Medical Technology, Komaki, Japan), which simultaneously measures pulse volumes in the brachial and posterior tibial arteries using an oscillometric method together with bilateral arm and ankle blood pressure. Both PWV and ABI were measured after allowing the patient to rest in the supine position for at least 5 min. For measuring brachial-ankle PWV, pulse volume waveforms of the brachial and tibial arteries were recorded. Details of the method have been described elsewhere. 27 After bilateral determination of brachial-ankle PWV, the higher value was taken as representative for each subject. ABI was calculated bilaterally as the ratio of systolic pressure in the ankle to systolic pressure in the arm, with the lower value considered representative for each subject.
Statistical analysis
Means and frequencies of potential confounding variables were calculated. Unpaired Student's t-tests or analyses of variance were conducted to assess statistical significance of differences between groups, using Stat View software (version 5.0; SAS Institute, Cary, NC). Because urinary albumin excretion showed skewed distributions, log transformation was carried out before performing correlation and regression analysis. The relationships between serum bilirubin concentrations and log (urinary albumin excretion), PWV, or ABI as well as the relationships between serum bilirubin concentrations and age, glycemic control or other variables were examined by Pearson's correlation analyses. To examine the effects of various factors on log (urinary albumin excretion), the following factors were considered simultaneously as independent variables for multiple regression analysis: serum bilirubin concentrations, age, sex, duration of diabetes, BMI, HbA1c, systolic blood pressure, serum total cholesterol, and triglyceride concentration and smoking status. All continuous variables are presented as the mean±s.d. A Pvalue o0.05 was considered statistically significant.
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